Evidence map›Paper›PMID 18079998›Full record

Trial reportMolecular medicine (Cambridge, Mass.)

alpha-Lipoic acid modulates extracellular matrix and angiogenesis gene expression in non-healing wounds treated with hyperbaric oxygen therapy.

Renata Alleva, Marco Tomasetti, Davide Sartini, Monica Emanuelli, Emanuele Nasole, Ferruccio Di Donato, Battista Borghi, Lory Santarelli, Jiri Neuzil

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Molecular medicine (Cambridge, Mass.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 31 citations in OpenAlex.

  1. Antiangiogenic Potential of Pomegranate Extracts.Plants (Basel, Switzerland) · 2024
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Hyperbaric oxygen effect on MMP-9 after a vascular insult.Journal of cardiovascular translational research · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Renata AllevaDepartment of Anesthesiology, IRCCS Istituti Ortopedici Rizzoli, Bologna, Italy. renalle@libero.it
Marco Tomasetti
Davide Sartini
Monica Emanuelli
Emanuele Nasole
Ferruccio Di Donato
Battista Borghi
Lory Santarelli
Jiri Neuzil
Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITCzech Academy of Sciences · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

alpha-Lipoic acid (LA) has been found previously to accelerate wound repair in patients affected by chronic wounds who underwent hyperbaric oxygen (HBO) therapy. Because proteinases are important in wound repair, we hypothesized that LA may regulate matrix metalloproteinase (MMP) expression in cells that are involved in wound repair. Patients undergoing HBO therapy were double-blind randomized into two groups: the LA group and the placebo group. Gene expression profiles for MMPs and for angiogenesis mediators were evaluated in biopsies collected at the first HBO session, at the seventh HBO session, and after 14 days of HBO treatment. ELISA tests were used to validate microarray expression of selected genes. LA supplementation in combination with HBO therapy downregulated the inflammatory cytokines and the growth factors which, in turn, affect MMPs expression. The disruption of the positive autocrine feedback loops that maintain the chronic wound state promotes progression of the healing process.

Indexed as

Gene Expression Regulation, EnzymologicHyperbaric OxygenationThioctic AcidWound HealingAgedAged, 80 and overAutocrine CommunicationBecaplerminDouble-Blind MethodExtracellular MatrixFeedback, PhysiologicalFemaleGene Expression ProfilingHumansInterleukin-1betaInterleukin-6BecaplerminInterleukin-1betaInterleukin-6Matrix MetalloproteinasesPlacebosPlatelet-Derived Growth FactorProto-Oncogene Proteins c-sisThioctic AcidTissue Inhibitor of MetalloproteinasesTumor Necrosis Factor-alpha

Identifiers

PMID18079998
PMCPMC2136431
OpenAlexW2096895252

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.